Tracy L. Hartman

1.0k total citations
36 papers, 874 citations indexed

About

Tracy L. Hartman is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Tracy L. Hartman has authored 36 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 25 papers in Virology and 12 papers in Molecular Biology. Recurrent topics in Tracy L. Hartman's work include HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (25 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Tracy L. Hartman is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV Research and Treatment (25 papers) and Pneumocystis jirovecii pneumonia detection and treatment (7 papers). Tracy L. Hartman collaborates with scholars based in United States, Belgium and South Korea. Tracy L. Hartman's co-authors include Robert W. Buckheit, Christophe Pannecouque, Erik De Clercq, Mark Cushman, Karen Watson, Bo‐Liang Deng, Jim A. Turpin, Matthew D. Cullen, John K. Inman and Ettore Appella and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tracy L. Hartman

35 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tracy L. Hartman United States 18 387 348 265 195 127 36 874
Akihiro Sugawara Japan 18 291 0.8× 199 0.6× 110 0.4× 404 2.1× 132 1.0× 60 928
Ayda Saldivar United States 14 314 0.8× 272 0.8× 170 0.6× 281 1.4× 137 1.1× 27 700
Steven Swaney United States 12 502 1.3× 643 1.8× 252 1.0× 534 2.7× 176 1.4× 14 1.6k
Marta Fernández‐González Spain 20 441 1.1× 428 1.2× 58 0.2× 465 2.4× 63 0.5× 50 1.2k
M. Janssen Belgium 20 442 1.1× 657 1.9× 583 2.2× 450 2.3× 146 1.1× 37 1.9k
Mervi Detorio United States 23 340 0.9× 1.1k 3.1× 848 3.2× 300 1.5× 269 2.1× 55 1.7k
A. McMillan United States 9 191 0.5× 779 2.2× 528 2.0× 338 1.7× 315 2.5× 10 1.0k
Anne M. Exall United Kingdom 16 403 1.0× 184 0.5× 49 0.2× 352 1.8× 106 0.8× 22 662
Mohamed Nasr United States 13 206 0.5× 199 0.6× 53 0.2× 231 1.2× 87 0.7× 31 631

Countries citing papers authored by Tracy L. Hartman

Since Specialization
Citations

This map shows the geographic impact of Tracy L. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy L. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy L. Hartman more than expected).

Fields of papers citing papers by Tracy L. Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy L. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy L. Hartman. The network helps show where Tracy L. Hartman may publish in the future.

Co-authorship network of co-authors of Tracy L. Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy L. Hartman. A scholar is included among the top collaborators of Tracy L. Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy L. Hartman. Tracy L. Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scerba, Michael T., et al.. (2019). The structure-activity profile of mercaptobenzamides’ anti-HIV activity suggests that thermodynamics of metabolism is more important than binding affinity to the target. European Journal of Medicinal Chemistry. 178. 818–837. 6 indexed citations
2.
Hartman, Tracy L., Liyuan Yang, Matthew Hassink, et al.. (2016). Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus. Antiviral Research. 134. 216–225. 14 indexed citations
3.
Bennett, Ryan P., Roger G. Ptak, Marie K. Mankowski, et al.. (2016). An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation. Antiviral Research. 136. 51–59. 28 indexed citations
4.
Sakamoto, Takeshi, Jun Takayama, Mari Okazaki, et al.. (2016). Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy. Bioorganic & Medicinal Chemistry. 24(13). 3006–3022. 7 indexed citations
5.
Quenelle, Debra C., et al.. (2014). Anti-HSV activity of serpin antithrombin III.. PubMed. 2(2). 87–92. 6 indexed citations
6.
Hartman, Tracy L., Lu Yang, & Robert W. Buckheit. (2011). Antiviral interactions of combinations of highly potent 2,4(1H,3H)-pyrimidinedione congeners and other anti-HIV agents. Antiviral Research. 92(3). 505–508. 7 indexed citations
7.
Conners, Gregory P., et al.. (2011). Was the Pediatric Emergency Department or Pediatric Urgent Care Center Setting More Affected by the Fall 2009 H1N1 Influenza Outbreak?. Clinical Pediatrics. 50(8). 764–766. 4 indexed citations
8.
Cullen, Matthew D., William C. Ho, Joseph D. Bauman, et al.. (2009). Crystallographic Study of a Novel Subnanomolar Inhibitor Provides Insight on the Binding Interactions of Alkenyldiarylmethanes with Human Immunodeficiency Virus-1 Reverse Transcriptase. Journal of Medicinal Chemistry. 52(20). 6467–6473. 9 indexed citations
9.
Wang, Deyun, Heather L. Baker, Roger G. Ptak, et al.. (2009). Multivalent binding oligomers inhibit HIV Tat–TAR interaction critical for viral replication. Bioorganic & Medicinal Chemistry Letters. 19(24). 6893–6897. 11 indexed citations
10.
Deng, Bo‐Liang, Yujie Zhao, Tracy L. Hartman, et al.. (2008). Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 44(3). 1210–1214. 28 indexed citations
11.
Cullen, Matthew D., Bo‐Liang Deng, Tracy L. Hartman, et al.. (2007). Synthesis and Biological Evaluation of Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors That Possess Increased Hydrolytic Stability. Journal of Medicinal Chemistry. 50(20). 4854–4867. 26 indexed citations
12.
Buckheit, Robert W., et al.. (2007). The Structure-Activity Relationships of 2,4(1H,3H)-pyrimidinedione Derivatives as potent HIV type 1 and type 2 inhibitors. Antiviral chemistry & chemotherapy. 18(5). 259–275. 32 indexed citations
13.
Cullen, Matthew D., Taradas Sarkar, Ernest Hamel, et al.. (2007). Inhibition of tubulin polymerization by select alkenyldiarylmethanes. Bioorganic & Medicinal Chemistry Letters. 18(2). 469–473. 7 indexed citations
14.
Fernández-Romero, José A., Stuart Turville, Kanani Titchen, et al.. (2006). Carrageenan/MIV-150 (PC-815), a Combination Microbicide. Sexually Transmitted Diseases. 34(1). 9–14. 75 indexed citations
15.
Deng, Bo‐Liang, Matthew D. Cullen, Zhigang Zhou, et al.. (2005). Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings. Bioorganic & Medicinal Chemistry. 14(7). 2366–2374. 77 indexed citations
16.
Horváth, András, Tracy L. Hartman, Karen Watson, et al.. (2005). Potent inhibition of HIV-1 entry by (s4dU)35. Virology. 334(2). 214–223. 16 indexed citations
17.
Xu, Guozhang, et al.. (2002). Synthesis of alkenyldiarylmethane (ADAM) non-Nucleoside HIV-1 reverse transcriptase inhibitors with non-Identical aromatic rings. Bioorganic & Medicinal Chemistry. 10(2). 283–290. 17 indexed citations
18.
Goel, Atul, Sharlyn J. Mazur, Rasem Fattah, et al.. (2002). Benzamide-Based Thiolcarbamates: A New Class of HIV-1 NCp7 Inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(5). 767–770. 106 indexed citations
19.
Xu, Guozhang, Tracy L. Hartman, Karen Watson, et al.. (2002). Synthesis of substituted diarylmethylenepiperidines (DAMPs), a novel class of anti-HIV agents. Bioorganic & Medicinal Chemistry. 10(8). 2807–2816. 11 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Sugawara Breakdown of academic impact, for papers by Ayda Saldivar Breakdown of academic impact, for papers by Steven Swaney Breakdown of academic impact, for papers by Marta Fernández‐González Breakdown of academic impact, for papers by M. Janssen Breakdown of academic impact, for papers by Mervi Detorio Breakdown of academic impact, for papers by A. McMillan Breakdown of academic impact, for papers by Anne M. Exall Breakdown of academic impact, for papers by Mohamed Nasr
Rankless by CCL
2026